We visited the Dialysis Vascular Access Research Group of the University of Cincinnati in April to discuss the possibility of clinical trial in the US.
The research group is led by Dr. Prabir Roy-Chaudhury. Its members include nephrologist, vascular surgeons, vascular physiologists, radiologists and other interdisciplinary experts. It is an important international research base of vascular access.
During the day, our product manager introduced the applicated status of WS Far-Infrared Therapy Unit in Taiwan and other countries, the relevant clinical experience and academic research results. The team members were impressed with the clinical data and result if Firapy, and discussed how to use it to solve clinical problems. After the meeting, we were so glad to hear the positive response from Dr. Prabir Roy-chaudhury. He said the “WS Far-Infrared Therapy Unit ” is a well applicable therapy, it is worth to introduce into the US to improve the fistula problem.